We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.
The US company, which has worked in conjunction with BioNtech, will submit its Emergency Use Authorisation request to the US Food and Drug Administration (FDA) later today. The coronavirus vaccine will then be ready to distribute within hours of authorisation. Pfizer and BioNTech is also seeking approval for their vaccine in other countries across the world, including the UK, Australia, Canada and Japan.
If the vaccine is approved in the US, it suggests a similar rollout of the treatment could soon take place in the UK.
The UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), is poised to fast-track authorisation of the vaccine.
More to follow…
Source: Read Full Article